Literature DB >> 15862993

Improvement of ACE inhibitory activity of chitooligosaccharides (COS) by carboxyl modification.

Ronghua Huang1, Eresha Mendis, Se-Kwon Kim.   

Abstract

In the present research, chitooligosaccharides (COS) were carboxylated with -COCH(2)CH(2)COO(-) groups to obtain specific structural features similar to Captopril. Angiotensin I converting enzyme (ACE) inhibitory activity of carboxylated COS was studied and observed to enhance its activity with increased substitution degree. Further, Lineweaver-Burk plot analysis revealed that inhibition was competitive via obligatory binding site of the enzyme. This was accompanied with substitution of positively charged quarternized amino groups to COS with different substitution degrees, in which negative impact on ACE inhibition was observed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15862993     DOI: 10.1016/j.bmc.2005.03.034

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  13 in total

Review 1.  Angiotensin-I-converting enzyme (ACE) inhibitors from marine resources: prospects in the pharmaceutical industry.

Authors:  Isuru Wijesekara; Se-Kwon Kim
Journal:  Mar Drugs       Date:  2010-03-31       Impact factor: 5.118

2.  Molecular weight dependent glucose lowering effect of low molecular weight Chitosan Oligosaccharide (GO2KA1) on postprandial blood glucose level in SD rats model.

Authors:  Sung-Hoon Jo; Kyoung-Soo Ha; Kyoung-Sik Moon; Jong-Gwan Kim; Chen-Gum Oh; Young-Cheul Kim; Emmanouil Apostolidis; Young-In Kwon
Journal:  Int J Mol Sci       Date:  2013-07-09       Impact factor: 5.923

3.  Biocompatibility and Alkaline Phosphatase Activity of Phosphorylated Chitooligosaccharides on the Osteosarcoma MG63 Cell Line.

Authors:  Jayachandran Venkatesan; Ratih Pangestuti; Zhong-Ji Qian; BoMi Ryu; Se-Kwon Kim
Journal:  J Funct Biomater       Date:  2010-10-22

4.  Membrane bioreactor technology for the development of functional materials from sea-food processing wastes and their potential health benefits.

Authors:  Se-Kwon Kim; Mahinda Senevirathne
Journal:  Membranes (Basel)       Date:  2011-10-25

5.  Antiproliferative Effect of Aminoethyl-Chitooligosaccharide on Human Lung A549 Cancer Cells.

Authors:  Dai Hung Ngo; Dai Nghiep Ngo; Se-Kwon Kim; Thanh Sang Vo
Journal:  Biomolecules       Date:  2019-05-18

6.  Cloning and Characterization of a New Chitosanase From a Deep-Sea Bacterium Serratia sp. QD07.

Authors:  Qiuling Zheng; Xiangjun Meng; Mingyang Cheng; Yanfeng Li; Yuanpeng Liu; Xuehong Chen
Journal:  Front Microbiol       Date:  2021-02-24       Impact factor: 5.640

Review 7.  Recent Advances in Marine-Based Nutraceuticals and Their Health Benefits.

Authors:  Vida Šimat; Nariman Elabed; Piotr Kulawik; Zafer Ceylan; Ewelina Jamroz; Hatice Yazgan; Martina Čagalj; Joe M Regenstein; Fatih Özogul
Journal:  Mar Drugs       Date:  2020-12-09       Impact factor: 5.118

Review 8.  Chitooligosaccharide and its derivatives: preparation and biological applications.

Authors:  Gaurav Lodhi; Yon-Suk Kim; Jin-Woo Hwang; Se-Kwon Kim; You-Jin Jeon; Jae-Young Je; Chang-Bum Ahn; Sang-Ho Moon; Byong-Tae Jeon; Pyo-Jam Park
Journal:  Biomed Res Int       Date:  2014-03-03       Impact factor: 3.411

9.  Effect of long-term supplementation of low molecular weight chitosan oligosaccharide (GO2KA1) on fasting blood glucose and HbA1c in db/db mice model and elucidation of mechanism of action.

Authors:  Jong-Gwan Kim; Sung-Hoon Jo; Kyoung-Soo Ha; Sung-Chul Kim; Young-Cheul Kim; Emmanouil Apostolidis; Young-In Kwon
Journal:  BMC Complement Altern Med       Date:  2014-07-29       Impact factor: 3.659

10.  Immunomodulatory Effects of N-Acetyl Chitooligosaccharides on RAW264.7 Macrophages.

Authors:  Jun-Jin Deng; Zong-Qiu Li; Ze-Quan Mo; Shun Xu; He-Hua Mao; Dan Shi; Zhi-Wei Li; Xue-Ming Dan; Xiao-Chun Luo
Journal:  Mar Drugs       Date:  2020-08-12       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.